Showing 1 - 14 results of 14 for search 'Liqing Kang', query time: 0.04s
Refine Results
-
1
Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells by Zhenyu Wei, Jiayu Xu, Chengkui Zhao, Chengkui Zhao, Min Zhang, Nan Xu, Nan Xu, Liqing Kang, Liqing Kang, Xiaoyan Lou, Xiaoyan Lou, Lei Yu, Lei Yu, Weixing Feng
Published 2023-10-01
Article -
2
Corrigendum: Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells by Zhenyu Wei, Jiayu Xu, Chengkui Zhao, Chengkui Zhao, Min Zhang, Nan Xu, Nan Xu, Liqing Kang, Liqing Kang, Xiaoyan Lou, Xiaoyan Lou, Lei Yu, Lei Yu, Weixing Feng
Published 2024-02-01
Article -
3
-
4
-
5
Investigation of CRS-associated cytokines in CAR-T therapy with meta-GNN and pathway crosstalk by Zhenyu Wei, Qi Cheng, Nan Xu, Chengkui Zhao, Jiayu Xu, Liqing Kang, Xiaoyan Lou, Lei Yu, Weixing Feng
Published 2022-09-01
Article -
6
Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review by Jiajie He, Jiajie He, Jiajie He, Rui Zou, Rui Zou, Rui Zou, Liqing Kang, Liqing Kang, Lingzi Yu, Lingzi Yu, Lingzi Yu, Peng Wang, Peng Wang, Yang Shao, Junheng Liang, Depei Wu, Depei Wu, Zhengming Jin, Zhengming Jin, Changju Qu, Changju Qu
Published 2023-11-01
Article -
7
Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma by Hairuo Wen, Xiaoyan Lou, Zhe Qu, Chao Qin, Hua Jiang, Ying Yang, Liqing Kang, Xingchao Geng, Lei Yu, Ying Huang
Published 2022-11-01
Article -
8
-
9
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab by Yurou Chu, Biqi Zhou, Rui Gao, Miao Miao, Huiying Qiu, Xiaowen Tang, Ying Wang, Suning Chen, Liqing Kang, Depei Wu, Yang Xu
Published 2025-02-01
Article -
10
P357: DECITABINE CONSOLIDATION AFTER CD19/CD22 CAR-T THERAPY IS A NOVEL STRATEGY TO IMPROVE OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA by Tingting LI, Qingya Cui, Sining Liu, Zheng LI, Wei Cui, Mengyun LI, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang
Published 2023-08-01
Article -
11
Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves sur... by Yunju Ma, Haiping Dai, Qingya Cui, Sining Liu, Liqing Kang, Xiaying Lian, Wei Cui, Jia Yin, Lingling Liu, Mengjie Cai, Lei Yu, Depei Wu, Xiaowen Tang
Published 2023-04-01
Article -
12
BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma by Yuhan Yan, Yixuan Tu, Qian Cheng, Jian Zhang, Erhua Wang, Zuqun Deng, Yan Yu, Liwen Wang, Rui Liu, Ling Chu, Liqing Kang, Jing Liu, Xin Li
Published 2024-11-01
Article -
13
CD19 chimeric antigen receptor-T cells as bridging therapy to allogeneic hematopoietic cell transplantation improves outcome in patients with refractory/relapsed B-cell acute lymph... by Jie Liu, Mengyuan Xu, Xiaoqian Zhang, Zhuo Zhang, Tao Zhong, Hongjuan Yu, Yueyue Fu, Hongbin Meng, Jiawei Feng, Xindi Zou, Xueying Han, Liqing Kang, Lei Yu, Limin Li
Published 2024-07-01
Article -
14
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion by Lei Yu, Yan Wang, Jin Wang, Zhiqiang Liu, Feng Liu, Han Zhao, Yi Tao, Jian-Qing Mi, Nan Xu, Wanyan Ouyang, Shi-Wei Jin, Wei-Yang Liu, Liuqingqing Zhang, Liqing Kang, Yuanfang Liu
Published 2024-04-01
Article